The TNF-α/ROS/HIF-1-induced upregulation of foxMI expression promotes HCC proliferation and resistance to apoptosis

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2250-2259

  Xia, Limin ^a,b   Mo, Ping ^a   Huang, Wenjie ^a   Zhang, Lin ^a   Wang, Ying ^a   Zhu, Hongwu ^a   Tian, Dean ^b   Liu, Jian ^a   Chen, Zhangqian ^a   Zhang, Yongguo ^a   Chen, Zheng ^a   Hu, Hao ^a   Fan, Daiming ^a   Nie, Yongzhan ^a   Wu, Kaichun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLIN B1; CYCLIN D1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 3; HYPOXIA INDUCIBLE FACTOR 4; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXMI; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY-FORMING UNITS ASSAY; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84868616470     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs249     Document Type: Article

References (46)

1. Balkwill, F. et al. (2001) Inflammation and cancer: back to Virchow? Lancet, 357, 539-545.
2. Castello, G. et al. (2010) HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin. Immunol., 134, 237-250.
3. Karin, M. et al. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol., 5, 749-759.
4. Feldmann, M. (2002) Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol., 2, 364-371.
5. Semenza, G.L. (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol., 88, 1474-1480.
6. Jaakkola, P. et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292, 468-472.
7. Mahon, P.C. et al. (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes. Dev., 15, 2675-2686.
8. Isaacs, J.S. et al. (2002) Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J. Biol. Chem., 277, 29936-29944.
9. Jiang, B.H. et al. (1997) Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem., 272, 19253-19260.
10. Gray, M.J. et al. (2005) HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene, 24, 3110-3120.
11. Patten, D.A. et al. (2010) Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol. Biol. Cell., 21, 3247-3257.
12. Page, E.L. et al. (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem., 277, 48403-48409.
13. Kim, I.M. et al. (2006) The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res., 66, 2153-2161.
14. Ye, H. et al. (1997) Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell. Biol., 17, 1626-1641.
15. Yao, K.M. et al. (1997) Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain. J. Biol. Chem., 272, 19827-19836.
16. Ye, H. et al. (1999) Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol. Cell. Biol., 19, 8570-8580.
17. Leung, T.W. et al. (2001) Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett., 507, 59-66.
18. Wang, X. et al. (2002) Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J. Biol. Chem., 277, 44310-44316.
19. Kalin, T.V. et al. (2006) Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res., 66, 1712-1720.
20. Liu, M. et al. (2006) FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res., 66, 3593-3602.
21. Calvisi, D.F. et al. (2009) Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut, 58, 679-687.
22. Ho, C. et al. (2012) AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. Hepatology, 55, 833-845.
23. Sun, H. et al. (2011) FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria. Cancer Lett., 306, 214-222.
24. Sun, H.C. et al. (2011) Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma. Oncol. Rep., 25, 1533-1539.
25. Kalinichenko, V.V. et al. (2004) Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev, 18, 830-850.
26. Gusarova, G.A. et al. (2007) A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J. Clin. Invest., 117, 99-111.
27. Xia, L.M. et al. (2009) Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1. J. Cell Biochem., 106, 247-256.
28. Bruix, J. et al. (2005) Management of hepatocellular carcinoma. Hepatology, 42, 1208-1236.
29. Horak, P. et al. (2010) Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A, 107, 4675-4680.
30. Koshikawa, N. et al. (2009) Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J. Biol. Chem., 284, 33185-33194.
31. Li, Q. et al. (2011) Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. J Biol Chem, 286, 40151-40162.
32. Almeida, M. et al. (2011) Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J. Biol. Chem., 286, 44326-44335.
33. Balkwill, F. (2009) Tumour necrosis factor and cancer. Nat Rev Cancer, 9, 361-371.
34. Pilarsky, C. et al. (2004) Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia, 6, 744-750.
35. Balli, D. et al. (2011) Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation. Oncogene. [Epub ahead of print]
36. Park, H.J. et al. (2009) FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J., 28, 2908-2918.
37. Wang, G.L. et al. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A., 92, 5510-5514.
38. Wang, G.L. et al. (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem, 270, 1230-1237.
39. Sundaresan, M. et al. (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science, 270, 296-299.
40. Pham, C.G. et al. (2004) Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell, 119, 529-542.
41. Finkel, T. (2000) Redox-dependent signal transduction. FEBS Lett., 476, 52-54.
42. Bulua, A.C. et al. (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med., 208, 519-533.
43. Aggarwal, B.B. (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol, 3, 745-756.
44. Wu, Y. et al. (2010) TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer., 102, 639-644.
45. Legler, D.F. et al. (2003) Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity, 18, 655-664.
46. Lavrik, I. et al. (2005) Death receptor signaling. J. Cell Sci., 118, 265-267.